Los Angeles-based Cedars-Sinai has received a $30 million gift from the Cayton Goldrich Family Foundation to establish the Cedars-Sinai Cayton BRCA Center.
The new center will focus on research, diagnosis and treatment of cancers linked to mutations in the BRCA1 and BRCA2 genes. BRCA gene mutations can increase the risk of several inherited cancers, including breast, ovarian, prostate and pancreatic malignancies.
The Cedars-Sinai Cayton BRCA Center will offer genetic testing, specialized screenings, risk-reducing procedures and reproductive medicine services. The facility is designed to provide personalized care for high-risk individuals and support translational research aimed at disrupting the progression of BRCA-related disease.
“Cedars-Sinai is truly humbled and honored by our continued visionary partnership with the Cayton Goldrich Family Foundation,” said Peter Slavin, MD, president and CEO of Cedars-Sinai and the David and Meredith Kaplan Presidential Chair. “They embody humanitarianism and hold a strong belief in science’s ability to transform healthcare and improve human life.”
Cedars-Sinai leaders said the center will be the first of its kind in Southern California and will help address care gaps for communities at elevated risk of BRCA mutations, including people of Eastern European Jewish, Korean, Mexican and African American ancestry.
About 1 in 400 people in the U.S. carry a BRCA mutation, but many are unaware due to under-testing and lack of access to specialized care, according to the release.
Leave a Reply